Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01522963 · ClinicalTrials.gov registry record · NA
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
A NA study, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 98
- Enrollment target
NCT01522963 is a NA study that has completed, run by University of Minnesota. The registered enrollment target is 98 participants.
The verdict
NCT01522963, a NA study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 98 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.
Interventions
- DRUG Nicotine lozenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2011-12 |
| Est. Completion | 2014-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01522963
The ClinicalTrials.gov registry entry for NCT01522963 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nicotine lozenge is the first listed.
NCT01522963 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01522963 about?
NCT01522963 is a clinical study titled "Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms". The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.
What is the current status of trial NCT01522963?
This trial is currently completed. It is a NA study. The enrollment target is 98 participants. The study started on 2011-12. Estimated completion is 2014-01.
What interventions are being tested in trial NCT01522963?
The interventions under investigation include: Nicotine lozenge (DRUG).
Who is sponsoring clinical trial NCT01522963?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.